About Our Offering Memorandum

Biopep Solutions Inc. is advancing innovative therapeutics in the field of oncology. Help us move our cancer research forward.

The current offering is an RRSP Eligible Investment + Investors May Apply to Receive 30% in B.C. Tax Credit.

  • We are looking to raise $5 Million to advance our cancer drug to the human trial testing stage
  • We are selling common shares at $0.75 per share and the deadline has been extended to March 1, 2018
  • We are in the last stage of pre-clinical testing
  • Plans for testing in cancer patients are being finalized at the BC Cancer Agency
  • Our drug demonstrates competative advantages over current therapies
  • Strong Scientific Advisory Board with qualified Management Team
  • Certified by the BC Govt as an Eligible Business Corporation
  • We hold patented Intellectual Property

01 You invest $5,000 or more in Biopep Solutions Inc.

02 Biopep Solutions Inc. uses your investment to further develop its novel anti-cancer drug, BPS-001, advancing it to the human trial testing stage.

03 You place the proceeds into a self-administered RRSP designated account and potentially reduce your net cost* and reduce your tax payable.

04 Apply to receive a 30% B.C. tax credit under the Small Business Venture Capital Act.

*Tax reduction from a contribution to an RRSP differs for individuals with different levels of taxable income. Please see your financial advisor to estimate your tax scenario and risk factor(s).